Ciprofloxacin vs Trimethoprim-Sulfamethoxazole
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Ciprofloxacin (Cipro) and trimethoprim-sulfamethoxazole (TMP-SMX, brand name Bactrim) are both oral antibiotics used for urinary tract infections, certain gastrointestinal infections, and other bacterial infections. They belong to different antibiotic classes with distinct side effect profiles.
Growing antibiotic resistance has changed prescribing patterns. TMP-SMX is generally recommended as first-line for uncomplicated UTIs, while ciprofloxacin is reserved for more complex infections.
Ciprofloxacin vs Trimethoprim-Sulfamethoxazole: Side-by-side comparison
| Category | Ciprofloxacin | Trimethoprim-Sulfamethoxazole |
|---|---|---|
| Drug Class | Fluoroquinolone | Sulfonamide/trimethoprim |
| Brand Name | Cipro | Bactrim, Septra |
| UTI Guideline Status | Second-line | First-line |
| Typical UTI Course | 3 days | 3 days |
| FDA Boxed Warning | Yes (tendon, nerve, CNS) | No |
| Key Side Effects | Tendon damage, neuropathy | Rash, hyperkalemia |
| Food Restrictions | Avoid dairy/calcium with dose | None significant |
Efficacy: How well does each drug work?
For uncomplicated UTIs, TMP-SMX is considered first-line by the IDSA when local resistance rates are below 20%. A 3-day course cures approximately 85-90% of uncomplicated UTIs. Ciprofloxacin is highly effective but is now second-line for simple UTIs to preserve its effectiveness for serious infections.
For complicated UTIs, kidney infections, and prostatitis, ciprofloxacin is often preferred due to its broader spectrum and excellent tissue penetration. Ciprofloxacin also treats traveler's diarrhea and certain bone and joint infections.
Antibiotic resistance is important to consider. In areas where TMP-SMX resistance exceeds 20%, ciprofloxacin or other alternatives may be necessary.
Side effects comparison
TMP-SMX is generally well tolerated. Common side effects include nausea, vomiting, and rash. Rarely, it can cause serious skin reactions (Stevens-Johnson syndrome). It can also cause hyperkalemia, especially in elderly patients on ACE inhibitors or ARBs.
Ciprofloxacin carries an FDA boxed warning for tendon rupture (especially Achilles), peripheral neuropathy, and CNS effects. These risks are higher in patients over 60 and those taking corticosteroids. The FDA advises that fluoroquinolones should not be used for uncomplicated infections when alternatives exist.
Both drugs can cause sun sensitivity and GI upset.
Cost comparison
Both are available as affordable generics. TMP-SMX costs approximately $4-$10 per course, and ciprofloxacin costs $8-$20 per course. Most insurance plans include both on generic discount programs.
Convenience and dosing
For uncomplicated UTIs, TMP-SMX is one double-strength tablet twice daily for 3 days. Ciprofloxacin is typically 250 mg twice daily for 3 days for simple UTIs.
Ciprofloxacin should not be taken with dairy, calcium-fortified foods, or antacids, as these reduce absorption. TMP-SMX has fewer dietary restrictions. Both interact with warfarin.
Which is right for you?
For most uncomplicated UTIs, TMP-SMX is the preferred first-line choice. It is effective, well tolerated, inexpensive, and preserves fluoroquinolones for serious infections.
Ciprofloxacin may be more appropriate for complicated UTIs, kidney infections, or TMP-SMX-resistant bacteria. It is also the choice if you have a sulfa allergy.
Your doctor will consider local resistance patterns, allergy history, and infection type when choosing. Completing the full course of any antibiotic is important to ensure clearance and reduce resistance.
Frequently asked questions
References
- [Observational] Cipro (ciprofloxacin) FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019537s086lbl.pdf Accessed 2026-03-01.
- [Observational] Bactrim (TMP-SMX) FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017377s068lbl.pdf Accessed 2026-03-01.
- [Observational] IDSA Guidelines for Uncomplicated UTIs https://pubmed.ncbi.nlm.nih.gov/21292654/ Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: